Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: psoriasis

Drug Updates: EULAR 2012

Michele B. Kaufman, PharmD, BCGP  |  August 8, 2012

Tracking the results of drug safety and efficacy

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsPsoriatic Arthritis Tagged with:BiologicsdrugEULARimagingInternationalMethotrexatePsoriatic ArthritisradiographRheumatoid arthritisrheumatologist

The Forward View in Rheumatology

Kimberly Retzlaff  |  July 9, 2012

Future leaders convene at the ACR/Arthritis Foundation Rheumatology Research Workshop to discuss cutting-edge research and career development.

Filed under:AwardsAxial SpondyloarthritisCareer DevelopmentConditionsEducation & TrainingOsteoarthritis and Bone DisordersProfessional TopicsResearch RheumRheumatoid ArthritisSystemic Lupus ErythematosusSystemic Sclerosis Tagged with:AC&RAmerican College of Rheumatology (ACR)AwardsCareer developmentimagingOsteoarthritispatient careResearchStem CellsUltrasound

The State-of-the-Art of Rheumatology Symposium

Lara C. Pullen, PhD  |  June 10, 2012

Experts from across the nation describe the best clinical approaches to rheumatologic disease management.

Filed under:ConditionsGout and Crystalline ArthritisResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatoryColchicineGoutHYDROXYCHLOROQUINELupuspatient carepregnancyResearchRheumatoid arthritisrheumatologistSystemic lupus erythematosus

Minerals, Mud, Martinis, and Methylprednisone

Simon M. Helfgott, MD  |  June 10, 2012

How the practice of rheumatology differs in America and Europe.

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesEULAR/OtherMeeting ReportsOpinionOsteoarthritis and Bone DisordersPain SyndromesRheumatoid ArthritisRheuminationsSpeak Out Rheum Tagged with:AC&RAmerican College of Rheumatology (ACR)Ankylosing Spondylitisanti-inflammatorydrugEULARFibromyalgiaglucocorticoidHelfgottMethotrexateOsteoarthritisradiographRheumatoid arthritisSteroids

Patient Fact Sheet: Juvenile Idiopathic Arthritis

Staff  |  May 9, 2012

Several types of arthritis fall under the JIA heading. This inflammation begins before patients reach the age of 16 years, and may involve one or many joints and cause other symptoms such as fevers, rash, and eye inflammation.

Filed under:Career DevelopmentConditionsEducation & TrainingFrom the CollegeProfessional TopicsPsoriatic ArthritisRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)inflammationJIAJuvenile idiopathic arthritispatient carepatient educationPediatricsPsoriatic ArthritisRheumatoid arthritisrheumatologist

Drug Updates: Citalopram hydrobromide, Statins, and More

Michele B. Kaufman, PharmD, BCGP  |  May 8, 2012

Information on new approvals and medication safety

Filed under:Drug Updates Tagged with:ApprovalsBiologicsdrugJAK inhibitorsjanus kinasePipelineRheumatoid arthritisSafetyStatin

Treatment Patterns and Trends for Spondylarthropathies

Vanessa Caceres  |  April 6, 2012

Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesPsoriatic Arthritis Tagged with:ACR/ARHP Annual MeetingAnkylosing Spondylitisanti-inflammatorydrugGlucocorticoidsMethotrexatepatient carePsoriatic ArthritisReactive arthritisRheumatoid arthritis

Maintenance of Certification Is Not Just for the Young

James R. O’Dell, MD  |  March 8, 2012

I certainly am relieved to know that I will never need to recertify with the American Board of Internal Medicine Maintenance of Certification, but this feeling is shadowed by a deep sense of shame. I decided to step up and take advantage of all the wonderful recertification programs the ACR has to offer.

Filed under:Career DevelopmentCertificationEducation & TrainingPresident's PerspectiveProfessional Topics Tagged with:AC&RAmerican College of Rheumatology (ACR)CertificationEducationeducation and trainingMOCrheumatologist

Where Will Kinase Inhibitors Fit into the RA Treatment Mix?

Vanessa Caceres  |  March 8, 2012

Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.

Filed under:ConditionsDrug UpdatesMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:ACR/ARHP Annual MeetingdrugImmunologyJAK inhibitorsjanus kinaseMethotrexatepatient careRAResearchRheumatoid arthritisTofacitinibTreatment

New Diagnostic Criteria for Axial Spondylarthritis

Ann Kepler  |  February 3, 2012

New name and classification criteria for ankylosing spondylitis may help with earlier diagnosis and treatment.

Filed under:Axial SpondyloarthritisClinical Criteria/GuidelinesConditions Tagged with:ACR/ARHP Annual MeetingAnkylosing Spondylitisanti-inflammatoryaxial spondyloarthritis (SpA)Diagnostic CriteriaimagingPainpatient careReactive arthritisSafety

  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences